Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 293,993 | 348,889 | 399,266 | 352,060 | 424,790 |
| Marketable Securities | 1,784,693 | 1,857,327 | 1,931,935 | 1,883,522 | 1,960,598 |
| Receivables | 27,259 | 5,140 | 97,778 | 142,359 | 27,956 |
| Inventories | 28,723 | 30,259 | 7,441 | 25,634 | 25,538 |
| Other current assets | 194,715 | 174,060 | 205,433 | 181,075 | 177,872 |
| TOTAL | $2,329,383 | $2,415,675 | $2,641,853 | $2,584,650 | $2,616,754 |
| Non-Current Assets | |||||
| PPE Net | 75,902 | 72,795 | 71,043 | 70,928 | 91,634 |
| Other Non-Current Assets | 285,843 | 275,458 | 277,176 | 278,393 | 262,743 |
| TOTAL | $361,745 | $348,253 | $348,219 | $349,321 | $354,377 |
| Total Assets | $2,691,128 | $2,763,928 | $2,990,072 | $2,933,971 | $2,971,131 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 44,332 | N/A | N/A |
| Accounts payable and accrued liabilities | 9,243 | 13,082 | 26,027 | 5,615 | 24,021 |
| Accrued Expenses | 149,348 | 127,585 | 215,621 | 152,749 | 134,067 |
| Other current liabilities | 8,799 | 9,988 | 8,831 | 9,952 | 8,903 |
| TOTAL | $306,162 | $327,648 | $448,090 | $404,210 | $287,975 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 41,836 | N/A | 16,436 |
| Deferred Revenues | 94,066 | 130,406 | 151,128 | 204,824 | 96,252 |
| Other Non-Current Liabilities | 1,932,567 | 1,924,677 | 1,872,276 | 1,965,029 | 1,984,021 |
| TOTAL | $2,121,268 | $2,139,765 | $2,155,296 | $2,214,301 | $2,254,855 |
| Total Liabilities | $2,427,430 | $2,467,413 | $2,603,386 | $2,618,511 | $2,542,830 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 146,211 | 145,965 | 145,752 | 143,472 | 143,326 |
| Common Shares | 146 | 146 | 144 | 143 | 143 |
| Retained earnings | -2,004,979 | -1,938,714 | -1,795,911 | -1,786,648 | -1,639,238 |
| Other shareholders' equity | -34,838 | -34,964 | -32,645 | -46,037 | -50,913 |
| TOTAL | $263,698 | $296,515 | $386,686 | $315,460 | $428,301 |
| Total Liabilities And Equity | $2,691,128 | $2,763,928 | $2,990,072 | $2,933,971 | $2,971,131 |